Denmark. Demant A/S

Date of agreement:26 Nov 2019
Country:Denmark
Customer:Demant A/S
Amount in DKK:DKK 450 million
Amount in EUR:EUR 60.2 million
Maturity:7 years
NACE sector / loan type:Research and development

Project

The loan has been provided to finance Demant’s R&D investments in 2019.

The company’s current R&D programme focuses on designing new wireless hearing devices and more effective acoustic implants. Demant is working in close cooperation with several universities and research centres, as well as the corporate sector, to improve its technology and products.

This is the third loan agreed between NIB and William Demant since 2015.

Demant A/S is an internationally leading company in the field of modern hearing solutions. The company is owned by William Demant Holding A/S. Listed on the Nasdaq Copenhagen since 1995, the group develops and manufactures hearing aids, diagnostic instruments and audiometric equipment to aid personal communication.

Fulfilment of NIB's mandate

Demant’s has a share of approximately 23% of the global hearing aid market, and the company’s R&D intensity has been increasing with its turnover. The ongoing research programme is mainly focusing on improved computational power and longevity, aiming to improve the user’s experience.

Sustainability summary

No significant sustainability concerns have been identified.

Press release
28.11.2019

NIB finances Danish hearing healthcare technology

Press release

NIB finansierer dansk teknologi til sundhedspleje inden for hørelse